Circulating miR-193b-3p has been reported to be upregulated in newly diagnosed, untreated individuals with T2D, and is believed to directly influence glucose metabolism by upregulating the transcription factor FOXO1, thereby enhancing the expression of gluconeogenic enzymes and promoting hepatic glucose production (12). The gene discussed is FOXO1; the disease is type 2 diabetes mellitus.